240 related articles for article (PubMed ID: 30692587)
1. Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases.
Liu JM; Yu CP; Chuang HC; Wu CT; Hsu RJ
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):475-482. PubMed ID: 30692587
[TBL] [Abstract][Full Text] [Related]
2. Androgen deprivation therapy for prostate cancer and the risk of thyroid diseases.
Liu JM; Chen YT; Wu CT; Hsu WL; Hsu RJ
Prostate; 2022 May; 82(7):809-815. PubMed ID: 35226371
[TBL] [Abstract][Full Text] [Related]
3. Androgen deprivation therapy and the risk of tenosynovitis in prostate cancer patients.
Liu JM; Liu DW; Chuang HC; Wu CT; Lin CY; Hsu RJ
Int Urol Nephrol; 2019 Jul; 51(7):1113-1119. PubMed ID: 31111393
[TBL] [Abstract][Full Text] [Related]
4. Androgen deprivation therapy for prostate cancer and the risk of hematologic disorders.
Liu JM; Liu YP; Chuang HC; Wu CT; Su YL; Hsu RJ
PLoS One; 2020; 15(2):e0229263. PubMed ID: 32074125
[TBL] [Abstract][Full Text] [Related]
5. Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer.
Liu JM; Chen TH; Chuang HC; Wu CT; Hsu RJ
Prostate Cancer Prostatic Dis; 2019 May; 22(2):276-283. PubMed ID: 30337635
[TBL] [Abstract][Full Text] [Related]
6. Association between ischaemic bowel syndromes and androgen deprivation therapy in patients with prostate cancer: a retrospective cohort study.
Chiang IN; Huang CY; Pu YS; Chang CH; Muo CH; Chung CJ; Wang RY; Young TH
BMJ Open; 2017 Feb; 7(2):e012950. PubMed ID: 28246133
[TBL] [Abstract][Full Text] [Related]
7. Incidence of autoimmune diseases in patients with scabies: a nationwide population-based study in Taiwan.
Liu JM; Chiu FH; Lin CY; Chang FW; Hsu RJ
Rheumatol Int; 2017 Jul; 37(7):1125-1134. PubMed ID: 28421357
[TBL] [Abstract][Full Text] [Related]
8. Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model.
Hong JH; Huang CY; Chang CH; Muo CH; Jaw FS; Lu YC; Chung CJ
Cancer Epidemiol; 2020 Feb; 64():101657. PubMed ID: 31918180
[TBL] [Abstract][Full Text] [Related]
9. Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate Cancer.
Klil-Drori AJ; Tascilar K; Yin H; Aprikian A; Bitton A; Azoulay L
Am J Epidemiol; 2016 Jul; 184(1):15-22. PubMed ID: 27268031
[TBL] [Abstract][Full Text] [Related]
10. Risk of incident autoimmune diseases in patients with newly diagnosed psoriatic disease: a nationwide population-based study.
Jung JM; Kim YJ; Lee WJ; Won CH; Lee MW; Chang SE
Sci Rep; 2023 Oct; 13(1):16738. PubMed ID: 37798369
[TBL] [Abstract][Full Text] [Related]
11. Risk of incident autoimmune diseases in patients with thymectomy.
Lin TM; Chang YS; Hou TY; Hsu HC; Lin SH; Chen WS; Kuo PI; Lin YC; Chen JH; Chang CC
Ann Clin Transl Neurol; 2020 Jul; 7(7):1072-1082. PubMed ID: 32478484
[TBL] [Abstract][Full Text] [Related]
12. Associations between Peripheral Thromboembolic Vascular Disease and Androgen Deprivation Therapy in Asian Prostate Cancer Patients.
Lu YC; Huang CY; Yeh HM; Hong JH; Chang CH; Muo CH; Chung SD; Yang TK; Jaw FS; Chung CJ
Sci Rep; 2019 Oct; 9(1):14231. PubMed ID: 31578427
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study.
Lin SH; Chang YS; Lin TM; Hu LF; Hou TY; Hsu HC; Shen YC; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
Front Immunol; 2021; 12():736036. PubMed ID: 34659225
[TBL] [Abstract][Full Text] [Related]
14. Androgen deprivation therapy and the risk of iron-deficiency anaemia among patients with prostate cancer: a population-based cohort study.
Wu FJ; Li IH; Chien WC; Shih JH; Lin YC; Chuang CM; Cheng YD; Kao LT
BMJ Open; 2020 Mar; 10(3):e034202. PubMed ID: 32213519
[TBL] [Abstract][Full Text] [Related]
15. Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population-based propensity score matching study.
Tae BS; Jeon BJ; Choi H; Bae JH; Park JY
Cancer Med; 2019 Aug; 8(9):4475-4483. PubMed ID: 31183968
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database.
Tae BS; Jeon BJ; Shin SH; Choi H; Bae JH; Park JY
Cancer Res Treat; 2019 Apr; 51(2):593-602. PubMed ID: 30025445
[TBL] [Abstract][Full Text] [Related]
17. Risk of developing hypertension after hormone therapy for prostate cancer: a nationwide propensity score-matched longitudinal cohort study.
Wu YH; Jhan JH; Ke HL; Tseng SI; Chang YH; Yeh HC; Li CC; Lee YC
Int J Clin Pharm; 2020 Dec; 42(6):1433-1439. PubMed ID: 32951178
[TBL] [Abstract][Full Text] [Related]
18. Decreased Risk of Renal Calculi in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer.
Lin CY; Liu JM; Wu CT; Hsu RJ; Hsu WL
Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32182733
[TBL] [Abstract][Full Text] [Related]
19. Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer.
Lin CC; Gray PJ; Jemal A; Efstathiou JA
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25957435
[TBL] [Abstract][Full Text] [Related]
20. Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism.
Klil-Drori AJ; Yin H; Tagalakis V; Aprikian A; Azoulay L
Eur Urol; 2016 Jul; 70(1):56-61. PubMed ID: 26138040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]